新型NDM-1抑制肽可增强美罗培南对产碳青霉烯酶肠杆菌的杀菌作用
本研究利用表面展示技术筛选能抑制NDM-1的合成肽,鉴定出约1700条可增强碳青霉烯依赖杀菌的序列,部分肽能穿透细菌周质直接结合NDM-1并抑制酶活性,且对哺乳动物细胞毒性低,为NDM-1抑制剂开发提供起点。
要点
- 鉴定出约1700条可增强碳青霉烯对NDM-1大肠杆菌杀菌的肽序列
- 先导肽穿透周质直接结合NDM-1抑制酶活性
- 先导肽溶血和细胞毒性低,可作为化学优化起点
核心结论
- 发现了可结合并抑制NDM-1的先导合成肽,能增强美罗培南对产碳青霉烯酶肠杆菌的杀菌作用。
研究设计与样本
- 利用表面展示技术筛选抑制NDM-1的肽,对先导序列化学合成并测定MBC和MIC。
- 用重组NDM-1进行动力学分析验证直接结合与抑制机制,并检测细胞毒性。
主要发现
- 鉴定出约1700条序列可增强碳青霉烯依赖的针对NDM-1大肠杆菌的杀伤。
- 若干序列还增强美罗培南依赖的其他产碳青霉烯酶肠杆菌的杀伤。
- 部分肽穿透细菌周质并直接结合NDM-1抑制酶活性。
- 各先导肽对哺乳动物细胞系溶血和细胞毒性极小。
临床怎么用
- 先导NDM-1抑制肽可作为进一步化学优化的起点,用于恢复碳青霉烯对产碳青霉烯酶肠杆菌的活性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Metallo-β-lactamases (MBLs) are an emerging class of antimicrobial resistance enzymes that degrade β-lactam antibiotics, including last-resort carbapenems. Infections caused by carbapenemase-producing Enterobacteriaceae (CPE) are increasingly prevalent, but treatment options are limited. While several serine-dependent β-lactamase inhibitors are formulated with commonly prescribed β-lactams, no MBL inhibitors are currently approved for combinatorial therapies. New compounds that target MBLs to restore carbapenem activity against CPE are therefore urgently needed. Herein we identified and characterized novel synthetic peptide inhibitors that bound to and inhibited NDM-1, which is an emerging β-lactam resistance mechanism in CPE. METHODS: We leveraged Surface Localized Antimicrobial displaY (SLAY) to identify and characterize peptides that inhibit NDM-1, which is a primary carbapenem resistance mechanism in CPE. Lead inhibitor sequences were chemically synthesized and MBCs and MICs were calculated in the presence/absence of carbapenems. Kinetic analysis with recombinant NDM-1 and select peptides tested direct binding and supported NDM-1 inhibitor mechanisms of action. Inhibitors were also tested for cytotoxicity. RESULTS: We identified approximately 1700 sequences that potentiated carbapenem-dependent killing against NDM-1 Escherichia coli. Several also enhanced meropenem-dependent killing of other CPE. Biochemical characterization of a subset indicated the peptides penetrated the bacterial periplasm and directly bound NDM-1 to inhibit enzymatic activity. Additionally, each demonstrated minimal haemolysis and cytotoxicity against mammalian cell lines. CONCLUSIONS: Our approach advances a molecular platform for antimicrobial discovery, which complements the growing need for alternative antimicrobials. We also discovered lead NDM-1 inhibitors, which serve as a starting point for further chemical optimization.
引用
- Kazi MI, Perry BW, Card DC, et al. Discovery and characterization of New Delhi metallo-β-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2020. PMID: 32591801. doi:10.1093/jac/dkaa242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。